SGS UNITED KINGDOM LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +2.2%

  £155,387,000 → £158,737,000

• Cash

  -23.5%

  £18,051,000 → £13,818,000

• Net assets

  +8.2%

  £69,723,000 → £75,434,000

• Employees

  +3.8%

  1,386 → 1,438

• Operating profit

  +146.8%

  £11,266,000 → £27,802,000

• Profit before tax

  +345.7%

  £12,080,000 → £53,841,000

• Wages

  +6.6%

  £65,027,000 → £69,330,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. SGS UNITED KINGDOM LIMITED 1992-01-01 → present
2. SGS INSPECTION SERVICES LIMITED 1989-11-09 → 1992-01-01
3. SGS (UNITED KINGDOM) LIMITED 1989-02-20 → 1989-11-09
4. SGS FREIGHT SERVICES LIMITED 1978-12-31 → 1989-02-20
5. SPEDICO (U.K.) LIMITED 1974-12-16 → 1978-12-31

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Forvis Mazars

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing the annual financial statements.”

Group structure

1. SGS UNITED KINGDOM LIMITED · parent
   1. SGS MIS Testing Limited 100% · England & Wales · Dormant
   2. SGS Vitrology Limited 100% · Scotland · Life Sciences

Significant events

• “On 1 January 2026 the company transferred in the trade, assets and liabilities of its sister company, SGS Quay Pharmaceuticals Limited.”
• “On the 16th October 2025, a shareholder resolution was passed to perform a full capital reduction on the share premium account.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.